HCR Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Hold |
924
| – | – | 0.04% | 186 |
|
|
2025
Q1 | $249K | Hold |
924
| – | – | 0.03% | 199 |
|
|
2024
Q4 | $217K | Hold |
924
| – | – | 0.03% | 213 |
|
|
2024
Q3 | $254K | Hold |
924
| – | – | 0.03% | 202 |
|
|
2024
Q2 | $225K | Buy |
+924
| New | +$225K | 0.03% | 208 |
|
|
2023
Q1 | – | Sell |
-924
| Closed | -$220K | – | 176 |
|
|
2022
Q4 | $220K | Buy |
+924
| New | +$220K | 0.05% | 158 |
|